|
ARMC10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41439999999482E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84670000002995E-06 |
| Normal-vs-Stage2 |
2.015700E-02 |
| Normal-vs-Stage3 |
8.492100E-02 |
| Normal-vs-Stage4 |
2.498100E-02 |
| Stage1-vs-Stage2 |
6.414800E-01 |
| Stage1-vs-Stage3 |
4.093800E-02 |
| Stage1-vs-Stage4 |
3.472400E-01 |
| Stage2-vs-Stage3 |
3.567000E-01 |
| Stage2-vs-Stage4 |
7.818000E-01 |
| Stage3-vs-Stage4 |
4.884200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01589999999641E-05 |
| Normal-vs-AfricanAmerican |
1.608560E-01 |
| Normal-vs-Asian |
4.749600E-01 |
| Caucasian-vs-AfricanAmerican |
1.258220E-01 |
| Caucasian-vs-Asian |
8.795400E-01 |
| AfricanAmerican-vs-Asian |
6.944000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.0952000000023E-05 |
| Normal-vs-Female |
7.046800E-04 |
| Male-vs-Female |
9.798400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.550800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.759400E-04 |
| Normal-vs-Age(61-80Yrs) |
6.23269999999732E-05 |
| Normal-vs-Age(81-100Yrs) |
6.307600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.846200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.481000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.980400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.623000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.077440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.404170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.068400E-01 |
| Normal-vs-Grade 2 |
1.44820000003154E-06 |
| Normal-vs-Grade 3 |
1.657170E-03 |
| Normal-vs-Grade 4 |
3.589200E-01 |
| Grade 1-vs-Grade 2 |
8.913600E-01 |
| Grade 1-vs-Grade 3 |
5.522200E-01 |
| Grade 1-vs-Grade 4 |
3.825200E-01 |
| Grade 2-vs-Grade 3 |
5.082300E-02 |
| Grade 2-vs-Grade 4 |
2.376000E-02 |
| Grade 3-vs-Grade 4 |
3.147200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.31970001593373E-09 |
| Normal-vs-ccB subtype |
6.210200E-02 |
| ccA subtype-vs-ccB subtype |
1.437600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.236900E-04 |
| Normal-vs-N1 |
5.514000E-01 |
| N0-vs-N1 |
5.284400E-01 |
|
|
